CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

RTTNews | 744 days ago
CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

(RTTNews) - CVS Health Corp. announced Wednesday the availability of updated 2024-2025 COVID-19 vaccines and flu vaccines at CVS Pharmacy and MinuteClinic locations across the United States.

The U.S. Food and Drug Administration recently approved and granted emergency use authorization or EUA for updated Covid vaccines (2024-2025 formula) from Pfizer Inc. and ModernaTX Inc. for use against currently circulating variants amid the increasing Covid cases in the country.

According to the Centers for Disease Control and Prevention or CDC, patients ages six months and older should receive the updated flu and COVID-19 vaccines, ideally in September or October, to restore and enhance protection against the most prevalent virus variants currently circulating.

Getting a flu vaccine and COVID-19 vaccine at the same time is recommended if patients are eligible and the timing for each vaccine is right, the company noted.

Patients can walk-in to any CVS Pharmacy and request a vaccination, and at the same time, can also schedule an appointment in advance at CVS.com or by using the CVS Pharmacy app. CVS said the digital vaccine scheduler has been updated to reflect available appointments at CVS Pharmacy and MinuteClinic.

The online vaccine scheduler offers the flexibility to schedule multiple patients (for up to four people) at once. This will allow families, caregivers, and others to get their vaccines together. Patients can also schedule multiple vaccinations in one appointment, such as flu, COVID-19, MMR and more.

Vaccination appointments are available at CVS Pharmacy, including locations inside Target and Schnucks, and MinuteClinic seven days a week, including during evenings and weekends.

read more
CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains

CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains

Shares of CVS Health Corp. were gaining around 5 percent in the pre-market activity on the NYSE on Wednesday, after the firm lifted fiscal 2026 profit and revenue outlook, after reporting significant growth in its second quarter. According to the health solutions major, the outlook revision reflects increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments.
RTTNews | 37 days ago
CVS Health Lifts FY26 Outlook After Q1 Results Rise; Stock Gains

CVS Health Lifts FY26 Outlook After Q1 Results Rise; Stock Gains

CVS Health Corp. on Wednesday reported higher profit and revenues in its first quarter and raised fiscal 2026 outlook. According to the health solutions major, the updated outlook reflects increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments. In pre-market activity, CVS shares were gaining around 4.7 percent
RTTNews | 128 days ago
CVS Health Q4 Beats Street, Confirms FY26 Earnings View; Stock Down

CVS Health Q4 Beats Street, Confirms FY26 Earnings View; Stock Down

CVS Health Corp., while reporting higher profit and revenues in its fourth quarter above market estimates, on Tuesday confirmed its earnings outlook for fiscal 2026. Further, the company trimmed guidance foer cash flow from operations to at least $9.0 billion from at least $10.0 billion expected earlier. In pre-market activity, the shares were losing around 3.9 percent.
RTTNews | 213 days ago
CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Corp. is conducting a strategic review of options including a possible breakup amid issues from its drugstore chain and Aetna health insurance arm, reports said citing person familiar with the matter. The company also plans to reduce its workforce by less than 1 percent, which would affect around 2,900 employees, as part of its cost-cutting efforts.
RTTNews | 710 days ago
CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024.
RTTNews | 863 days ago
P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

Consumer goods giant Procter & Gamble Co. has called back around 8.2 million defective bags of Tide, Gain, Ace and Ariel laundry detergent packets distributed in the United States citing risk of serious injury, the U.S. Consumer Product Safety Commission announced. In addition, about 56,741 were sold in Canada. According to the agency, the outer packaging meant to prevent access to the contents...
RTTNews | 886 days ago
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 921 days ago
CVS Health Lowers FY24 Outlook - Update

CVS Health Lowers FY24 Outlook - Update

While reporting financial results for the fourth quarter on Wednesday, CVS Health (CVS) lowered its earnings and adjusted earnings guidance for the full-year 2024.
RTTNews | 947 days ago